Fundraising FoxAnchordx
Guangzhou, CN · 3 known investors
Find your way into Anchordx
Sign up to find every way you can get introduced to Anchordx
- Your email: who you already know at Anchordx, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Anchordx team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
AnchorDx develops, manufactures, and sells cancer early-screening and diagnostic products based on ctDNA methylation high-throughput sequencing, along with related testing services covering over 70% of high-incidence cancers such as lung, breast, digestive, and urinary cancers. Founded in 2015 in Guangzhou, China with R&D centers in China and the US, it also runs a big-data and AI platform focused on lung cancer detection and treatment.
Founders & leadership
Investors · 3
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Frequently asked questions
- What does Anchordx do?
- AnchorDx develops, manufactures, and sells cancer early-screening and diagnostic products based on ctDNA methylation high-throughput sequencing, along with related testing services covering over 70% of high-incidence cancers such as lung, breast, digestive, and urinary cancers. Founded in 2015 in Guangzhou, China with R&D centers in China and the US, it also runs a big-data and AI platform focused on lung cancer detection and treatment.
- Who founded Anchordx?
- Anchordx was founded by 范建兵.
- Who are Anchordx's investors?
- Anchordx's investors include Marathon Venture Partners, OrbiMed, 6 Dimensions Capital.
- Where is Anchordx headquartered?
- Anchordx is headquartered in Guangzhou, CN.